TY - JOUR
T1 - Clinical significance of the parental origin of the X chromosome in Turner syndrome
AU - Sagi, Liora
AU - Zuckerman-Levin, Nehama
AU - Gawlik, Aneta
AU - Ghizzoni, Lucia
AU - Buyukgebiz, Atilla
AU - Rakover, Yardena
AU - Bistritzer, Tzvi
AU - Admoni, Osnat
AU - Vottero, Alessandra
AU - Baruch, Oshrat
AU - Fares, Fuad
AU - Malecka-Tendera, Ewa
AU - Hochberg, Ze'ev
PY - 2007/3
Y1 - 2007/3
N2 - Context: The phenotype in Turner syndrome (TS) is variable, even in patients with a supposedly nonmosaic karyotype. Previous work suggested that there were X-linked parent-of-origin effects on the phenotype. Hypothesis: The TS phenotype is influenced by the parental origin of the missed X chromosome. Design: This was a multicenter prospective study of TS patients and both their parents, determining parental origin of the X-chromosome, and characterizing the clinical phenotype. Patients and Methods: Eighty-three TS patients and their parents were studied. Inclusion criteria were TS with karyotype 45,X or 46Xi(Xq). Four highly polymorphic microsatellite markers on the X-chromosome DMD49, DYSII, DXS1283, and the androgen receptor gene and three Y chromosome markers, SRY, DYZ1, and DYZ3. Outcome Measures: The study determined the correlation between the parental origin of the X chromosome and the unique phenotypic traits of TS including congenital malformations, anthropometry and growth pattern, skeletal defects, endocrine traits, education, and vocation. Results: Eighty-three percent of 45,X retained their maternal X (Xm), whereas 64% 46Xi(Xq) retained their paternal X (Xp, P < 0.001). Kidney malformations were exclusively found in Xm patients (P = 0.030). The Xm group had lower total and low-density lipoprotein cholesterol (P < 0.003), and higher body mass index SD score (P = 0.030) that was not maintained after GH treatment. Response to GH therapy was comparable. Ocular abnormalities were more common in the paternal X group (P = 0.017), who also had higher academic achievement. Conclusions: The parental origin of the missing short arm of the X chromosome has an impact on overweight, kidney, eye, and lipids, which suggests a potential effect of an as-yet-undetermined X chromosome gene imprinting.
AB - Context: The phenotype in Turner syndrome (TS) is variable, even in patients with a supposedly nonmosaic karyotype. Previous work suggested that there were X-linked parent-of-origin effects on the phenotype. Hypothesis: The TS phenotype is influenced by the parental origin of the missed X chromosome. Design: This was a multicenter prospective study of TS patients and both their parents, determining parental origin of the X-chromosome, and characterizing the clinical phenotype. Patients and Methods: Eighty-three TS patients and their parents were studied. Inclusion criteria were TS with karyotype 45,X or 46Xi(Xq). Four highly polymorphic microsatellite markers on the X-chromosome DMD49, DYSII, DXS1283, and the androgen receptor gene and three Y chromosome markers, SRY, DYZ1, and DYZ3. Outcome Measures: The study determined the correlation between the parental origin of the X chromosome and the unique phenotypic traits of TS including congenital malformations, anthropometry and growth pattern, skeletal defects, endocrine traits, education, and vocation. Results: Eighty-three percent of 45,X retained their maternal X (Xm), whereas 64% 46Xi(Xq) retained their paternal X (Xp, P < 0.001). Kidney malformations were exclusively found in Xm patients (P = 0.030). The Xm group had lower total and low-density lipoprotein cholesterol (P < 0.003), and higher body mass index SD score (P = 0.030) that was not maintained after GH treatment. Response to GH therapy was comparable. Ocular abnormalities were more common in the paternal X group (P = 0.017), who also had higher academic achievement. Conclusions: The parental origin of the missing short arm of the X chromosome has an impact on overweight, kidney, eye, and lipids, which suggests a potential effect of an as-yet-undetermined X chromosome gene imprinting.
UR - http://www.scopus.com/inward/record.url?scp=33947498699&partnerID=8YFLogxK
U2 - 10.1210/jc.2006-0158
DO - 10.1210/jc.2006-0158
M3 - Article
C2 - 17192299
AN - SCOPUS:33947498699
SN - 0021-972X
VL - 92
SP - 846
EP - 852
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 3
ER -